the

ZAlloy: The Future of Cleveland Golf Wedges

HUNTINGTON BEACH, Calif., July 1, 2025 – From the Cleveland 588 Tour Action to the ground-breaking RTX ZipCore, Cleveland Golf…

1 year ago

Metabolon’s Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D)

Combining metabolomics, gut microbiome, and clinical data may help prevent and personalize the treatment of type 2 diabetes MORRISVILLE, N.C.,…

1 year ago

FAIR PLAY MENARINI INTERNATIONAL AWARD, LUIS FIGO JOINS THE GREAT SPORTS STARS ACKNOWLEDGED IN 2025

FLORENCE, Italy, July 1, 2025 /PRNewswire/ -- Surprises never end when it comes to the Fair Play Menarini International Award:…

1 year ago

Minelab Unveils the GOLD MONSTER 2000: More Precision. More Depth. More Gold

ADELAIDE, Australia, July 1, 2025 /PRNewswire/ -- Minelab is proud to announce the launch of the GOLD MONSTER 2000, a fully…

1 year ago

TraceLink’s MINT Named “Supply Chain Transparency Solution of the Year” in 2025 SupplyTech Breakthrough Awards

The award recognizes MINT for enabling real-time, end-to-end visibility across critical supply chain transactions and processes BOSTON, July 1, 2025…

1 year ago

IMG Launches First ‘Student Journey Scholarship’ for International Students in the U.S.

INDIANAPOLIS, July 1, 2025 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is…

1 year ago

New Glassnode Report: How Bybit’s Response to the Lazarus Hack Became Crypto’s Defining Stress Test

DUBAI, UAE, July 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been featured in a…

1 year ago

CNRC Announces Change in Control, New Management and the Deployment of the Cutting-Edge KUBERA Technology to Enhance Oil and Gas Detection and Exploration

CHARLESTON, W.Va., July 1, 2025 /PRNewswire/ -- Cunningham Natural Resources Corp (OTC: CNRC) ("CNRC" or the "Company") announced today that Aruna…

1 year ago

Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis

July 01, 2025 09:00 ET  | Source: Inmagene Biopharmaceuticals The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007…

1 year ago

Visory Health Wins Gold at the 2025 Digital Health Awards

ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health, a leading patient-first health tech prescription platform that is transforming…

1 year ago